Syngene International has concluded the acquisition of a biologics manufacturing facility from Stelis Biopharma for a revised gross value of Rs 617 crores.
AI Assistant
Syngene International Ltd
2023
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.